Skip to main content

Table 6 Number of subjects who rated as Good, Neutral or Poor in terms of CVD risk reduction, from Day 0 to Day 28

From: A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Type of FA Score OS™(EPA + DPA + DHA) ω-3 SES E + DSES ω-3 RBCES Total Total minus E + DSES
rTG Good 26 26 9 27 88 79
Concentrated Neutral 6 6 23 5 40 17
Triglyceride Poor 0 0 0 0 0 0
EE Good 19 23 10 16 68 58
Ethyl ester Neutral 12 6 21 15 54 33
  Poor 1 3 1 1 6 5
PL Good 14 12 7 10 43 36
Phospho- Neutral 15 14 23 19 71 48
lipid (krill) Poor 3 6 2 3 14 12
TG Good 18 12 7 9 46 39
Triglyceride Neutral 10 15 25 21 71 46
  Poor 4 5 0 2 11 11
  1. OS™: OmegaScore™; ω-3 SES: Omega-3 Serum Equivalence Score; E + DSES: EPA + DHA Serum Equivalence Score; ω-3 RBCES: Omega-3 Red Blood Cell Equivalence Score (Omega-3 Index).